Let’s be honest: The newscycle these days feels like a constant reel of sad, bad, and often, downright chaos. The headlines swirling in behavioral health and substance use disorder (SUD) treatment are no exception. Since H.R.1 was signed into law on July 4, 2025, the commentary has ranged from urgent to alarmist. Policy breakdowns. Think […]
In the wake of the One Big Beautiful Bill Act (OBBBA)—a.k.a. H.R.1—behavioral health and SUD leaders are facing an onslaught of new funding pressures, administrative complexity, and operational uncertainty. This webinar focuses less on the flashy headlines about impacts to the Medicaid system—and more on what executive teams can do now to protect client access, […]
As 2025 comes to a close, I’m proud of what the Eleos team delivered this year to support almost 40,000 clinicians in helping over a million Americans with the most advanced AI in behavioral health. In service of our mission, our footprint expanded meaningfully in 2025: Here is my roundup of the top moments from […]
H.R.1—also known as the One Big Beautiful Bill Act (OBBBA)—debuted back in July, and as we head into peak cookie-baking season, it feels like ages ago. But while plenty has happened since the law passed, we’re still waiting on some key ingredients from the Centers for Medicare & Medicaid Services (CMS) that haven’t been fully […]
The One Big Beautiful Bill Act (OBBBA)—also known as H.R.1—and its sweeping budget cuts have quickly become the biggest news in healthcare since the Affordable Care Act (ACA), and for good reason. With mounting funding uncertainty and millions of Americans expected to lose coverage, the entire healthcare system is bracing for impact. In a recent […]
When we kicked off the No Notes podcast last year, our goal was simple: Bring together the brightest minds in behavioral health to talk candidly about the issues keeping leaders up at night. Fast-forward to today, and the response has been nothing short of mic-drop-worthy. Each season has grown and evolved, giving us a front-row […]
Subscribe now to get all the latest updates
